-+ 0.00%
-+ 0.00%
-+ 0.00%

AbbVie Exec Says Plans To Start Enrolling Apogee's Zumilokibart This Year, Targets Launch In Early 2030; Says Will Present Late-stage Data For Blood Cancer Drug Etentamig At International Myeloma Society Meeting Later In September

Benzinga·09/15/2026 14:30:30
Listen to the news

https://event.webcasts.com/starthere.jsp?ei=1773801&tp_key=756e5e03ad&tp_special=8